SEC Form 4/A · accession 0001192482-19-000090
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Geraldine Henwood
Officer — President and CEO · Director
Period of report
Jan 18, 2019
Accepted (ET)
Feb 19, 2019 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F6 | Jan 18, 2019 | A | 40,864 | $0.00 | A | 215,872 | D | |
| Common StockF2 | Jan 18, 2019 | M | 5,000 | — | A | 220,872 | D | |
| Common StockF3 | Jan 18, 2019 | F | 1,425 | $7.99 | D | 219,447 | D | |
| Common Stock | holding | — | — | — | 50,000 | I | By: Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6,F4 | $7.99 | Jan 18, 2019 | A | 190,700 | A | — | Jan 18, 2029 | Common Stock | 190,700 | 190,700 | D |
| Restricted Stock UnitsF2,F5 | — | Jan 18, 2019 | M | 5,000 | D | — | — | Common Stock | 5,000 | 10,000 | D |
Explanation of responses
- F1All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
- F2Restricted stock units convert into common stock on a one-for-one basis.
- F3Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- F4The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.
- F5On January 18, 2017, the reporting person was granted 20,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- F6Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted.